000 01736 a2200493 4500
005 20250515230026.0
264 0 _c20110131
008 201101s 0 0 eng d
022 _a1879-0712
024 7 _a10.1016/j.ejphar.2010.05.043
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLu, Yong
245 0 0 _aGallic acid suppresses cell viability, proliferation, invasion and angiogenesis in human glioma cells.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cSep 2010
300 _a102-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBlotting, Western
650 0 4 _aBrain Neoplasms
_xgenetics
650 0 4 _aCell Line
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xgenetics
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDown-Regulation
650 0 4 _aEndothelial Cells
_xmetabolism
650 0 4 _aGallic Acid
_xmetabolism
650 0 4 _aGlioma
_xgenetics
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aNeoplasms
_xpathology
650 0 4 _aNeovascularization, Pathologic
_xmetabolism
650 0 4 _aProto-Oncogene Proteins c-akt
_xgenetics
700 1 _aJiang, Feng
700 1 _aJiang, Hao
700 1 _aWu, Kalina
700 1 _aZheng, Xuguang
700 1 _aCai, Yizhong
700 1 _aKatakowski, Mark
700 1 _aChopp, Michael
700 1 _aTo, Shing-Shun Tony
773 0 _tEuropean journal of pharmacology
_gvol. 641
_gno. 2-3
_gp. 102-7
856 4 0 _uhttps://doi.org/10.1016/j.ejphar.2010.05.043
_zAvailable from publisher's website
999 _c19903034
_d19903034